Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A temperature-sensitive gel medicine preparation and a preparation method thereof

A temperature-sensitive gel and pharmaceutical preparation technology, which is applied in the directions of drug combination, pharmaceutical formulation, aerosol delivery, etc., can solve the problem of not achieving the sustained release effect of the preparation, achieve good reference value and application significance, and improve medication compliance. Effect

Active Publication Date: 2014-03-12
SHANGHAI MODERN PHARMA ENG INVESTIGATION CENT
View PDF3 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] The technical problem to be solved by the present invention is to overcome the problem that the water-soluble drug in the water-soluble drug temperature-sensitive gel is easy to diffuse out through the water-soluble channel inside the gel, causing most of the drug to be released at the initial stage of the drug, and serious drug damage will occur for a period of time after the drug is taken. Burst release effect, not reaching the sustained release effect of preparations and other defects, but provides a temperature-sensitive gel pharmaceutical preparation that is particularly suitable for water-soluble drugs, reduces the burst release effect, and can slowly release drugs and its preparation method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A temperature-sensitive gel medicine preparation and a preparation method thereof
  • A temperature-sensitive gel medicine preparation and a preparation method thereof
  • A temperature-sensitive gel medicine preparation and a preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-2

[0083] Polymer A: hydrophilic PLGA-PEG-PLGA copolymer (polymer A, 1571-1500-1571, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.15) ; Polymer B: appropriate amount of hydrophobic PLGA-PEG-PLAG copolymer (polymer B, 1255-1500-1255, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.23 ).

[0084] Wherein, the synthesis process of polymers A and B refers to the synthesis methods in Examples 1 and 3 of the Chinese patent application with application number 200910049664.6.

[0085] Get polymer A and polymer B, add deionized water, dissolve under magnetic stirring, configure polymer, the weight ratio of polymer A / polymer B is 1 / 1, and the total polymer concentration is 25% (w / The aqueous solution of w) was passed through a 0.22 μm filter membrane for later use, and was...

Embodiment 3-4

[0090] Polymer A: hydrophilic PLGA-PEG-PLGA copolymer (polymer A, 1571-1500-1571, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.15) ; Polymer B: appropriate amount of hydrophobic PLGA-PEG-PLAG copolymer (polymer B, 1255-1500-1255, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.23 ).

[0091] Wherein, the synthesis process of polymers A and B refers to the synthesis methods in Examples 1 and 3 of the Chinese patent application with application number 200910049664.6.

[0092] Get polymer A and polymer B, add deionized water, dissolve under magnetic stirring, configure polymer, the weight ratio of polymer A / polymer B is respectively 1 / 1, and total polymer concentration is 25% (w / The aqueous solution of w) was passed through a 0.22 μm filter membrane for later use...

Embodiment 5-6

[0097]Polymer A: hydrophilic PLGA-PEG-PLGA copolymer (polymer A, 1571-1500-1571, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.15) ; Polymer B: appropriate amount of hydrophobic PLGA-PEG-PLAG copolymer (polymer B, 1255-1500-1255, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.23 ).

[0098] Wherein, the synthesis process of polymers A and B refers to the synthesis methods in Examples 1 and 3 of the Chinese patent application with application number 200910049664.6.

[0099] Get polymer A and polymer B, add deionized water, dissolve under magnetic stirring, configure polymer, the weight ratio of polymer A / polymer B is respectively 1 / 1, and total polymer concentration is 25% (w / The aqueous solution of w) was passed through a 0.22 μm filter membrane for later use,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a temperature-sensitive gel medicine preparation and a preparation method thereof. A raw material formula of the temperature-sensitive gel medicine preparation comprises a medicine, a temperature-sensitive gel composition, and an auxiliary material C. The auxiliary material C is one or more selected from a metal salt, a carbohydrate and a hydrophilic polymer used for injection medicines. The metal salt is a pharmaceutically acceptable metal salt which can dissociate divalent metal cation in a water solution. The medicine is a compound A which exists in an anion state in a water solution. The compound A is one or more selected from a protein type medicine, a polypeptide type medicine and a glycopeptides type antibiotic. The preparation method comprises a step of dissolving the medicine into the temperature-sensitive gel composition existing in a solution form according to the raw material formula. The temperature-sensitive gel medicine preparation is especially suitable for water-soluble medicines, and is capable of diminishing burst release effects and releasing the medicine slowly, thus achieving an objective of slow release.

Description

technical field [0001] The invention relates to a temperature-sensitive gel pharmaceutical preparation and a preparation method thereof. Background technique [0002] Exenatide (also known as exenatide or exendin-4) was first isolated from the saliva secretion of giant monster lizard (Heloderm suspectum), and it is a polypeptide containing 39 amino acids (Eng, J. et al., J.Biol. Chem., 1990 (265): 20259-20262; Or J.Biol.Chem., 1992 (267): 7402-7405), its amino acid sequence and class glucagon (glucagon-like peptide-1, GLP-1 ) has about 53% of the same components. Pharmacological studies have found that exenatide has a similar effect to GLP-1, that is, it can stimulate pancreatic β cells to secrete insulin. Exenatide can act on GLP-1 receptors on certain insulin-secreting cells in vitro, on interspersed acinar cells from the pancreas of guinea pigs, or on parietal cells from the stomach; it has also been reported that Exenatide The peptide stimulates somatostatin release a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/06A61K47/34A61K38/17A61P3/10
Inventor 李坤陈庆华刘晓君包泳初潘峰韩蕾房超
Owner SHANGHAI MODERN PHARMA ENG INVESTIGATION CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com